BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

  March 24, 2026

   · 

  19 min read
• Press Releases

  Spectral Medical and Vantive Announce Publication of Complete Results from Spectral’s Tigris Trial in the Lancet Respiratory Medicine

  March 24, 2026

   · 

  13 min read
• Press Releases

  CAMP4 Appoints Michael MacLean to its Board of Directors

  March 24, 2026

   · 

  8 min read
• Press Releases

  Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

  March 24, 2026

   · 

  10 min read
• Press Releases

  NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

  March 24, 2026

   · 

  9 min read
• Press Releases

  Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

  March 24, 2026

   · 

  7 min read
• Press Releases

  Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

  March 24, 2026

   · 

  5 min read
• Press Releases

  Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers

  March 24, 2026

   · 

  6 min read
• Press Releases

  Opus Genetics Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026

  March 24, 2026

   · 

  3 min read
• Press Releases

  Outlook Therapeutics Announces Pricing of $5.0 Million Public Offering

  March 24, 2026

   · 

  5 min read